Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice. / Villanueva, Erika B; Tresse, Emilie; Liu, Yawei; Duarte, João N; Jimenez-Duran, Gisela; Ejlerskov, Patrick; Kretz, Oliver; Loreth, Desiree; Goldmann, Tobias; Prinz, Marco; Issazadeh-Navikas, Shohreh.

In: Annals of Neurology, Vol. 90, No. 5, 2021, p. 789-807.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Villanueva, EB, Tresse, E, Liu, Y, Duarte, JN, Jimenez-Duran, G, Ejlerskov, P, Kretz, O, Loreth, D, Goldmann, T, Prinz, M & Issazadeh-Navikas, S 2021, 'Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice', Annals of Neurology, vol. 90, no. 5, pp. 789-807. https://doi.org/10.1002/ana.26209

APA

Villanueva, E. B., Tresse, E., Liu, Y., Duarte, J. N., Jimenez-Duran, G., Ejlerskov, P., Kretz, O., Loreth, D., Goldmann, T., Prinz, M., & Issazadeh-Navikas, S. (2021). Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice. Annals of Neurology, 90(5), 789-807. https://doi.org/10.1002/ana.26209

Vancouver

Villanueva EB, Tresse E, Liu Y, Duarte JN, Jimenez-Duran G, Ejlerskov P et al. Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice. Annals of Neurology. 2021;90(5):789-807. https://doi.org/10.1002/ana.26209

Author

Villanueva, Erika B ; Tresse, Emilie ; Liu, Yawei ; Duarte, João N ; Jimenez-Duran, Gisela ; Ejlerskov, Patrick ; Kretz, Oliver ; Loreth, Desiree ; Goldmann, Tobias ; Prinz, Marco ; Issazadeh-Navikas, Shohreh. / Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice. In: Annals of Neurology. 2021 ; Vol. 90, No. 5. pp. 789-807.

Bibtex

@article{185580c4f2c842af87ebf3b4f9d01b77,
title = "Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice",
abstract = "OBJECTIVE: Parkinson's disease (PD) manifests in motor dysfunction, non-motor symptoms, and eventual dementia (PDD). Neuropathological hallmarks include nigrostriatal neurodegeneration, Lewy body (LB) pathology, and neuroinflammation. Alpha-synuclein (α-syn), a primary component of LBs, is implicated in PD pathogenesis, accumulating and aggregating in both familial and sporadic PD. However, as α-syn pathology is often comorbid with amyloid-beta (Aβ) plaques and phosphorylated tau (pTau) tangles in PDD, it is still unclear whether α-syn is the primary cause of neurodegeneration in sporadic PDD. We aimed to determine how the absence of α-syn would affect PDD manifestation.METHODS: IFN-β knockout (Ifnb-/- ) mice spontaneously develop progressive behavior abnormalities and neuropathology resembling PDD, notably with α-syn+ LBs. We generated Ifnb/Snca double knockout (DKO) mice and evaluated their behavior and neuropathology compared with wild-type (Wt), Ifnb-/- , and Snca-/- mice using immunohistochemistry, electron microscopy, immunoblots, qPCR, and modification of neuronal signaling.RESULTS: Ifnb/Snca DKO mice developed all clinical PDD-like behavioral manifestations induced by IFN-β loss. Independently of α-syn expression, lack of IFN-β alone induced Aβ plaques, pTau tangles, and LB-like Aβ+ /pTau+ inclusion bodies and neuroinflammation. IFN-β loss caused significant elevated glial and neuronal TNF-α and neuronal TNFR1, associated with neurodegeneration. Restoring neuronal IFN-β signaling or blocking TNFR1 rescued caspase 3/t-BID-mediated neuronal-death through upregulation of c-FLIPS and lowered intraneuronal Aβ and pTau accumulation.INTERPRETATION: These findings increase our understanding of PD pathology and suggest that targeting α-syn alone is not sufficient to mitigate disease. Targeting specific aspects of neuroinflammation, such as aberrant neuronal TNF-α/TNFR1 or IFN-β/IFNAR signaling, may attenuate disease. This article is protected by copyright. All rights reserved.",
keywords = "Faculty of Health and Medical Sciences, alpha-synuclein, amyloid-beta, interferon-beta, neuroinflammation, Parkinson's disease dementia, phosphorylated tau, tumor necrosis factor alpha, alpha-synuclein, amyloid-beta, interferon-beta, neuroinflammation, Parkinson's disease dementia, phosphorylated tau, tumor necrosis factor alpha",
author = "Villanueva, {Erika B} and Emilie Tresse and Yawei Liu and Duarte, {Jo{\~a}o N} and Gisela Jimenez-Duran and Patrick Ejlerskov and Oliver Kretz and Desiree Loreth and Tobias Goldmann and Marco Prinz and Shohreh Issazadeh-Navikas",
year = "2021",
doi = "10.1002/ana.26209",
language = "English",
volume = "90",
pages = "789--807",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "JohnWiley & Sons, Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Neuronal TNFα, not α-syn, underlies PDD-like disease progression in IFNβ-KO mice

AU - Villanueva, Erika B

AU - Tresse, Emilie

AU - Liu, Yawei

AU - Duarte, João N

AU - Jimenez-Duran, Gisela

AU - Ejlerskov, Patrick

AU - Kretz, Oliver

AU - Loreth, Desiree

AU - Goldmann, Tobias

AU - Prinz, Marco

AU - Issazadeh-Navikas, Shohreh

PY - 2021

Y1 - 2021

N2 - OBJECTIVE: Parkinson's disease (PD) manifests in motor dysfunction, non-motor symptoms, and eventual dementia (PDD). Neuropathological hallmarks include nigrostriatal neurodegeneration, Lewy body (LB) pathology, and neuroinflammation. Alpha-synuclein (α-syn), a primary component of LBs, is implicated in PD pathogenesis, accumulating and aggregating in both familial and sporadic PD. However, as α-syn pathology is often comorbid with amyloid-beta (Aβ) plaques and phosphorylated tau (pTau) tangles in PDD, it is still unclear whether α-syn is the primary cause of neurodegeneration in sporadic PDD. We aimed to determine how the absence of α-syn would affect PDD manifestation.METHODS: IFN-β knockout (Ifnb-/- ) mice spontaneously develop progressive behavior abnormalities and neuropathology resembling PDD, notably with α-syn+ LBs. We generated Ifnb/Snca double knockout (DKO) mice and evaluated their behavior and neuropathology compared with wild-type (Wt), Ifnb-/- , and Snca-/- mice using immunohistochemistry, electron microscopy, immunoblots, qPCR, and modification of neuronal signaling.RESULTS: Ifnb/Snca DKO mice developed all clinical PDD-like behavioral manifestations induced by IFN-β loss. Independently of α-syn expression, lack of IFN-β alone induced Aβ plaques, pTau tangles, and LB-like Aβ+ /pTau+ inclusion bodies and neuroinflammation. IFN-β loss caused significant elevated glial and neuronal TNF-α and neuronal TNFR1, associated with neurodegeneration. Restoring neuronal IFN-β signaling or blocking TNFR1 rescued caspase 3/t-BID-mediated neuronal-death through upregulation of c-FLIPS and lowered intraneuronal Aβ and pTau accumulation.INTERPRETATION: These findings increase our understanding of PD pathology and suggest that targeting α-syn alone is not sufficient to mitigate disease. Targeting specific aspects of neuroinflammation, such as aberrant neuronal TNF-α/TNFR1 or IFN-β/IFNAR signaling, may attenuate disease. This article is protected by copyright. All rights reserved.

AB - OBJECTIVE: Parkinson's disease (PD) manifests in motor dysfunction, non-motor symptoms, and eventual dementia (PDD). Neuropathological hallmarks include nigrostriatal neurodegeneration, Lewy body (LB) pathology, and neuroinflammation. Alpha-synuclein (α-syn), a primary component of LBs, is implicated in PD pathogenesis, accumulating and aggregating in both familial and sporadic PD. However, as α-syn pathology is often comorbid with amyloid-beta (Aβ) plaques and phosphorylated tau (pTau) tangles in PDD, it is still unclear whether α-syn is the primary cause of neurodegeneration in sporadic PDD. We aimed to determine how the absence of α-syn would affect PDD manifestation.METHODS: IFN-β knockout (Ifnb-/- ) mice spontaneously develop progressive behavior abnormalities and neuropathology resembling PDD, notably with α-syn+ LBs. We generated Ifnb/Snca double knockout (DKO) mice and evaluated their behavior and neuropathology compared with wild-type (Wt), Ifnb-/- , and Snca-/- mice using immunohistochemistry, electron microscopy, immunoblots, qPCR, and modification of neuronal signaling.RESULTS: Ifnb/Snca DKO mice developed all clinical PDD-like behavioral manifestations induced by IFN-β loss. Independently of α-syn expression, lack of IFN-β alone induced Aβ plaques, pTau tangles, and LB-like Aβ+ /pTau+ inclusion bodies and neuroinflammation. IFN-β loss caused significant elevated glial and neuronal TNF-α and neuronal TNFR1, associated with neurodegeneration. Restoring neuronal IFN-β signaling or blocking TNFR1 rescued caspase 3/t-BID-mediated neuronal-death through upregulation of c-FLIPS and lowered intraneuronal Aβ and pTau accumulation.INTERPRETATION: These findings increase our understanding of PD pathology and suggest that targeting α-syn alone is not sufficient to mitigate disease. Targeting specific aspects of neuroinflammation, such as aberrant neuronal TNF-α/TNFR1 or IFN-β/IFNAR signaling, may attenuate disease. This article is protected by copyright. All rights reserved.

KW - Faculty of Health and Medical Sciences

KW - alpha-synuclein

KW - amyloid-beta

KW - interferon-beta

KW - neuroinflammation

KW - Parkinson's disease dementia

KW - phosphorylated tau

KW - tumor necrosis factor alpha

KW - alpha-synuclein

KW - amyloid-beta

KW - interferon-beta

KW - neuroinflammation

KW - Parkinson's disease dementia

KW - phosphorylated tau

KW - tumor necrosis factor alpha

U2 - 10.1002/ana.26209

DO - 10.1002/ana.26209

M3 - Journal article

C2 - 34476836

VL - 90

SP - 789

EP - 807

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -

ID: 279126834